Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis

NCT00004747 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

NIH

Sponsor class

Conditions

Cystic Fibrosis
Bacterial Infections

Interventions

DRUG: mucoid exopolysaccharide P. aeruginosa immune globulin IV

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]